Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial

Objective. To investigate the safety and efficacy of MLC601 (NeuroAid) as a traditional Chinese medicine on motor recovery after ischemic stroke. Methods. This study was a double-blind, placebo-controlled clinical trial on 150 patients with a recent (less than 1 month) ischemic stroke. All patients...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Harandi, R. Abolfazli, A. Hatemian, K. Ghragozlee, M. Ghaffar-Pour, M. Karimi, S. Shahbegi, H. Pakdaman, M. Tabasi, A. L. Tabatabae, A. Nourian
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Stroke Research and Treatment
Online Access:http://dx.doi.org/10.4061/2011/721613
Tags: Add Tag
No Tags, Be the first to tag this record!